GR1001222B - Μεθοδος προσδιορισμου eπιπεδων εξωτερικων και εσωτερικων παραγοντων πηγματοποιησης και πρωτεινη c - Google Patents

Μεθοδος προσδιορισμου eπιπεδων εξωτερικων και εσωτερικων παραγοντων πηγματοποιησης και πρωτεινη c

Info

Publication number
GR1001222B
GR1001222B GR900100852A GR900100852A GR1001222B GR 1001222 B GR1001222 B GR 1001222B GR 900100852 A GR900100852 A GR 900100852A GR 900100852 A GR900100852 A GR 900100852A GR 1001222 B GR1001222 B GR 1001222B
Authority
GR
Greece
Prior art keywords
protein
reaction rate
clot formation
clotting factors
determining levels
Prior art date
Application number
GR900100852A
Other languages
English (en)
Other versions
GR900100852A (en
Inventor
J Carroll James
M Autenrieth Stephen
Original Assignee
Ortho Diagnostic Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostic Systems Inc filed Critical Ortho Diagnostic Systems Inc
Publication of GR900100852A publication Critical patent/GR900100852A/el
Publication of GR1001222B publication Critical patent/GR1001222B/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Μιας μεθόδου προσδιορισμού επιπέδων εξωτερικών και εσωτερικών παραγόντων πηγματοποίησης και πρωτεϊνης C, βασισμένη πάνω στον ρυθμό αντίδρασης του παρατηρούμενου σχηματισμού πήγματος και παρέχεται το πρώτο παράγωγο του ρυθμού αντίδρασης του παρατηρούμενου σχηματισμού πήγματος. Σύμφωνα με τις υποδείξεις της εφεύρεσης, ο ρυθμός αντίδρασης του παρατηρούμενου σχηματισμού πήγματος σε μια δοκιμή χρόνου προθρομβίνης ή σε μια δοκιμή χρόνου ενεργοποιημένης μερικής προθρομβίνης προσδιορίζεται τόσο για τα δείγματα δοκιμής όσο και κανονικού πλάσματος και οι ρυθμοί αντίδρασης συγκρίνονται. Σε μια άλλη πρακτική εφαρμογή, το πρώτο παράγωγο του ρυθμού αντίδρασης του παρατηρούμενου σχηματισμού πήγματος προσδιορίζεται και τα αποτελεσματα συγκρίνονται. ω
GR900100852A 1989-12-19 1990-12-11 Μεθοδος προσδιορισμου eπιπεδων εξωτερικων και εσωτερικων παραγοντων πηγματοποιησης και πρωτεινη c GR1001222B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/452,802 US5169786A (en) 1989-12-19 1989-12-19 Method of determining levels of extrinsic and intrinsic clotting factors and protein c

Publications (2)

Publication Number Publication Date
GR900100852A GR900100852A (en) 1992-05-12
GR1001222B true GR1001222B (el) 1993-06-21

Family

ID=23797999

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100852A GR1001222B (el) 1989-12-19 1990-12-11 Μεθοδος προσδιορισμου eπιπεδων εξωτερικων και εσωτερικων παραγοντων πηγματοποιησης και πρωτεινη c

Country Status (8)

Country Link
US (1) US5169786A (el)
EP (1) EP0434377B1 (el)
AT (1) ATE126894T1 (el)
CA (1) CA2032561C (el)
DE (1) DE69021849T2 (el)
DK (1) DK0434377T3 (el)
ES (1) ES2088992T3 (el)
GR (1) GR1001222B (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114135A (en) * 1991-11-08 2000-09-05 Goldstein; Sheldon Multiple coagulation test system and method of using a multiple coagulation test system
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
WO1993010261A1 (en) * 1991-11-13 1993-05-27 Dahlbaeck Bjoern Method for the diagnosis of blood coagulation disorders
DE69233376T2 (de) * 1992-11-12 2005-06-30 Sheldon Goldstein Testvorrichtung und verfahren für vielfachgerinnungstest
CZ184995A3 (en) * 1993-01-29 1996-03-13 Bjorn Dahlback Novel anticoagulative cofactor activity
US5378431A (en) * 1993-06-14 1995-01-03 Becton, Dickinson And Company Dual pathway clotting enhancer for blood collection tube
DK0633473T3 (da) * 1993-06-30 1999-08-09 Stiftung F R Diagnostische For Måling af den aktiverede partielle thromboplastin-tid (APTT) i en reaktion i et enkelt trin
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US6867045B1 (en) 1994-11-14 2005-03-15 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
US20030143759A1 (en) * 1995-10-20 2003-07-31 Bjorn Dahlback Assays for determining anticoagulant cofactor activity
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
US5839443A (en) 1996-05-16 1998-11-24 The Trustees Of Columbia University In The City Of New York Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
DE19724239A1 (de) * 1997-06-09 1998-12-10 Max Planck Gesellschaft Dysprothrombinämie
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
US6194394B1 (en) * 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
US6524861B1 (en) 1999-01-22 2003-02-25 Medical Laboratory Automation, Inc. Blood coagulation analyzer
JP4486260B2 (ja) * 1999-02-04 2010-06-23 バイオメリュー・インコーポレイテッド 患者サンプルにおける止血機能不全の存在を予測するための方法および装置
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
JP2003524187A (ja) * 2000-02-23 2003-08-12 ベッスト−テスト アンパーツゼルスカブ 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
JP2008531692A (ja) * 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
WO2011159820A1 (en) * 2010-06-15 2011-12-22 Bayer Healthcare Llc Device
US20140038205A1 (en) * 2011-02-18 2014-02-06 Precision Biologic Inc. Methods and compositions relating to coagulation assays
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
US10816559B2 (en) 2014-09-29 2020-10-27 Ca Casyso Ag Blood testing system and method
CN107748267B (zh) * 2017-10-13 2019-02-26 山东艾科达生物科技有限公司 一种测定活化部分凝血活酶时间（aptt）的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3307392A (en) * 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) * 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) * 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) * 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
GB8426004D0 (en) * 1984-10-15 1984-11-21 Ortho Diagnostic Systems Inc Coagulation monitoring
IT1197891B (it) * 1986-10-17 1988-12-21 Instrumentation Lab Spa Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti

Also Published As

Publication number Publication date
ATE126894T1 (de) 1995-09-15
US5169786A (en) 1992-12-08
DE69021849D1 (de) 1995-09-28
GR900100852A (en) 1992-05-12
CA2032561C (en) 2000-04-18
DE69021849T2 (de) 1995-12-21
DK0434377T3 (da) 1995-09-25
CA2032561A1 (en) 1991-06-20
EP0434377A1 (en) 1991-06-26
EP0434377B1 (en) 1995-08-23
ES2088992T3 (es) 1996-10-01

Similar Documents

Publication Publication Date Title
GR900100852A (en) Method of determining levels of extrinsing and intrinsic clotting factors and protein c
ATE311601T1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
US5051357A (en) Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
ATE35000T1 (de) Reagenz zur bestimmung der thromboplastinzeit.
Rooney et al. The Taipan snake venom time: a new test for lupus anticoagulant.
EP0420332A3 (en) Method for determining the endogenous thrombin potential of plasma and blood, and also a kit or use in said method
EP0236985A3 (en) Method for the photometric determination of protein c and/or protein s activity
EP0661383A3 (de) Verfahren zur Bestimmung der Thrombozytenaggregation
Vinazzer et al. Protein C: comparison of different assays in normal and abnormal plasma samples
EP1367135A1 (en) Improved method for the assessment of thrombin formation in blood or plasma
DE69610558D1 (en) Test für thrombosegefahr
AU2893697A (en) Method of carrying out blood tests
AU8600082A (en) Radioimmunoassay for fibrinopeptide a using a tripeptide thrombin inhibitor
DE3267870D1 (en) Reagent for the optical determination of blood clotting reaction
AU6385498A (en) Reagent for determining aptt
US6051434A (en) Activated protein C resistance test
DE59309374D1 (de) Reagens zur Bestimmung der aktivierten partiellen Thromboplastinzeit (aPTT)
DK0570354T3 (da) Fremgangsmåde til bestemmelse af fibrinogen
FI932194A0 (fi) Anvaendningen av protrombinfragment
AUPP159698A0 (en) Improved blood coagulation test
ATE191278T1 (de) Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen
Toulon et al. ProC global: a new assay to evaluate the functionality of the protein C anticoagulant pathway preliminary results in 223 consecutive patients with a history of venous thromboembolism
ATE200710T1 (de) Verfahren zur diagnose von blutgerinnungsstörungen
UA31304A (uk) Спосіб прогнозування тромботичних ускладнень в акушерській практиці

Legal Events

Date Code Title Description
MA Right expired

Effective date: 20101212